Ketamine has been extensively researched as one of the best treatments for depression. Individuals suffering from long-term depression know how hard it can be to be in and out of 10+ treatments that don’t work. However, ketamine is a person’s last resort.
It works wonders and has multiple studies backing its effectiveness. Depending on the intensity of your condition, your KAP therapist will curate a unique treatment plan. However, these are just the basics of ketamine and depression that most people would know.
But there is so much more you wouldn’t know. Our article is an intermediate insight into everything about ketamine and depression. We have covered why ketamine is different, the medication, neuroplasticity, how the treatment works, what it looks like, and who should consider this treatment.
What Is Ketamine?
You may already know ketamine as an anesthetic. However, in mental health, ketamine is now more popular as a treatment for depression. The medication itself has many effects on your body, especially neuroplasticity, the main reason why ketamine is effective for depression.
When used for mental health treatment, ketamine is administered under strict medical supervision in licensed clinical settings, with careful screening, dosing, and monitoring to ensure safety and therapeutic effectiveness.
How Traditional Antidepressants Work
Traditional antidepressants, most commonly selective serotonin reuptake inhibitors (SSRIs), work by increasing the availability of serotonin in the brain. Serotonin is a neurotransmitter involved in mood regulation, sleep, appetite, and emotional balance. SSRIs prevent serotonin from being reabsorbed too quickly, allowing it to stay active longer between nerve cells.
Why SSRIs help many people:
- Reduce symptoms of depression and anxiety over time.
- Take a safe prescription for depression, which is widely studied when prescribed correctly.
- Stabilize mood for many individuals with mild to moderate depression.
However, SSRIs don’t work for everyone. Some people experience limited relief, delayed results, or side effects that make continued use difficult.
How Ketamine Works Differently
Ketamine works through a completely different brain pathway than traditional antidepressants. Instead of targeting serotonin, ketamine acts primarily on the glutamate system, the most abundant neurotransmitter system in the brain. Glutamate plays a key role in how brain cells communicate, adapt, and form new connections.
This matters because glutamate is directly involved in neuroplasticity, the brain’s ability to reorganize itself, strengthen neural pathways, and recover from the effects of chronic stress and depression. In people with depression, these communication pathways can become weakened or disrupted over time.
Why targeting glutamate is important.
- It enhances communication between brain cells rather than simply adjusting chemical levels.
- It promotes the formation of new neural connections linked to mood and cognition.
- It may help “reset” rigid or negative thought patterns associated with depression.
Because of this, ketamine can produce therapeutic effects much more rapidly than traditional antidepressants for some individuals.
Unlike SSRIs, which gradually influence mood through serotonin modulation, ketamine introduces a fundamentally different mechanism, one focused on repairing and strengthening neural networks. This distinction is why ketamine-assisted psychotherapy is often considered when standard treatments have not provided sufficient relief.
Depression, Rigidity, and the Brain
Depression is a complex neuropsychiatric disorder that goes beyond transient sadness; it frequently involves rigid cognitive and emotional patterns that persist despite insight or effort. Clinical studies from NIH demonstrate that depression is associated with altered brain network connectivity and functional organization, reflecting changes in how multiple neural circuits communicate and adapt over time.
Rigidity in depression manifests as perseverative negative thinking, reduced cognitive flexibility, and inflexible behavioral responses, which correlate with impaired synaptic plasticity and disrupted communication between prefrontal and limbic regions.
From a neurobiological perspective, these patterns reflect deficits in neural plasticity, the brain’s capacity to remodel synaptic connections in response to experience or environmental demands.
Understanding depression as involving neural rigidity rather than simple mood dysregulation underscores why some individuals fail to respond adequately to traditional monoaminergic treatments and highlights the rationale for interventions that target plasticity mechanisms like ketamine.
Neuroplasticity: Creating New Pathways
If you have researched ketamine, you might’ve seen the word “neuroplasticity” mentioned in every study or article. This is the main function the medicine performs. It helps the brain repair, reorganize, and form new neural connections. Here is more about neuroplasticity.
What Neuroplasticity Means
Neuroplasticity refers to the brain’s ability to change its structure and function in response to experience. In practical terms, it is how the brain forms new connections, strengthens useful pathways, and weakens patterns that are no longer adaptive. This capacity underlies learning, emotional regulation, and recovery from psychological stress.
In depression, neuroplasticity is often reduced, contributing to rigid thinking, emotional narrowing, and repetitive negative patterns.
How Ketamine Increases Brain Flexibility
Ketamine is believed to temporarily enhance neuroplasticity by acting on the glutamate system and downstream signaling pathways involved in synaptic growth. This can lead to a short-term increase in neural flexibility, during which the brain becomes more receptive to change.
Key effects observed in clinical and preclinical research include:
- Increased synaptic connectivity
- Enhanced communication between brain regions
- Reduced dominance of entrenched neural patterns
Why This Window Matters for Therapy
This temporary state of heightened plasticity creates a therapeutic window. During this period, patients may be more able to access emotions, reframe core beliefs, and form new psychological insights. When psychotherapy is intentionally integrated, these experiences can be consolidated into longer-lasting cognitive and emotional change, forming the foundation of ketamine-assisted psychotherapy (KAP).
What Ketamine Treatment Looks Like
Every KAP therapist you approach will always offer their own custom KAP delivery. However, there are some basics to KAP therapy that guide how your ketamine therapy sessions will look:
Routes of Administration
Ketamine can be delivered through several medically supervised routes, depending on clinical goals, patient history, and provider expertise. Common methods include intravenous (IV) infusion, intranasal administration, intramuscular (IM) injection, and oral or sublingual formulations. Each route differs in onset time, intensity, and duration of effects.
- IV ketamine allows precise dosing and a rapid onset.
- Intranasal esketamine is FDA-approved for treatment-resistant depression.
- IM and oral/sublingual ketamine are widely used off-label in clinical practice.
Monitoring, Safety, and Clinical Structure
Ketamine treatment is conducted in structured medical or clinical settings with continuous monitoring. Patients are typically assessed before treatment for medical and psychiatric suitability, including cardiovascular status, substance use history, and diagnostic clarity.
During administration, clinicians monitor:
- Blood pressure, heart rate, and oxygen saturation
- Level of consciousness and psychological response
- Adverse effects such as dissociation, nausea, or anxiety
Sessions follow standardized protocols, with recovery periods and post-treatment observation before discharge. Patients are advised not to drive and to arrange transportation home.
FDA Approval and Off-Label Use
It is important to distinguish between FDA-approved and off-label uses. Intranasal esketamine (Spravato®) is FDA-approved for treatment-resistant depression and depressive symptoms associated with suicidal ideation, when used alongside an oral antidepressant. Other ketamine formulations, particularly IV racemic ketamine, are used off-label but are supported by a growing body of clinical research and practice guidelines.
Integration and Follow-Up
In ketamine-assisted psychotherapy (KAP), dosing sessions are paired with preparation and integration therapy. This structure helps patients process the experience, reinforce therapeutic insights, and translate neurobiological changes into sustained psychological benefit.
Who Might Consider Ketamine
Ketamine-based interventions are typically considered for adults with treatment-resistant depression, defined clinically as persistent depressive symptoms after trials of at least two adequate antidepressant treatments and psychotherapy without sustained benefit. This includes individuals with major depressive disorder and, in selected cases, bipolar depression with mood stabilization, where conventional monoaminergic strategies have been insufficient.
Patients often considered include:
- Those with severe depression that significantly impairs their function
- Individuals with treatment-resistant symptoms despite multiple trials of SSRIs/SNRIs/psychotherapy only
- Patients with acute suicidal ideation requiring rapid symptom reduction (in monitored clinical settings)
- Selected cases of comorbid anxiety or PTSD refractory to standard care
It is important to clarify that ketamine is not reserved for those who are “desperate,” but for patients meeting specific clinical criteria where the evidence suggests potential benefit. Clinicians should also acknowledge normal hesitation due to off-label use and limited mainstream familiarity, necessitating thorough informed consent and risk–benefit discussion.
What Ketamine Is—and Is Not
Ketamine is a pharmacological tool that can support therapeutic change, but it is not a cure for depression or other mental health conditions. While some individuals experience rapid symptom relief, ketamine does not eliminate the underlying causes of distress or replace the need for ongoing psychological care.
What Ketamine Is
- A clinically administered medication that may enhance neuroplasticity and emotional flexibility when used under medical supervision
- A therapeutic catalyst that works best when integrated with structured psychotherapy and post-session integration
What Ketamine Is Not
- A cure, quick fix, or replacement for ongoing mental health care
- A daily, take-home antidepressant or a standalone treatment without therapeutic support
This is the reason why many KAP therapists in Philadelphia usually follow a balanced approach, integrating psychotherapy with ketamine (ketamine-assisted psychotherapy).
Conclusion
Ketamine and depression go hand in hand. However, accessing the right ketamine therapy is important. If you are new to ketamine, understanding how it works, reviewing the studies, and researching the right ketamine provider can help you land the appropriate treatment for your depression.
That’s why many patients and clinicians partner with The Ko-Op. We offer:
For patients:
Safe and effective ketamine-assisted psychotherapy (KAP). Our team of KAP precribers and therapists offers online and in-person sessions that can help you gain access to affordable KAP care.
To start a free consult for KAP, click here.
For therapists:
We provide training, consultation, prescriber partnerships, legal forms, and more resources a therapist might need to get started with KAP. You can start with one-time packages and move on to memberships with us.
To start exploring our resources, click here.
Reach out to us to understand ketamine and depression better.
